Robert L. Hudkins's most recent trade in Tyra Biosciences Inc was a trade of 1,040 Common Stock done at an average price of $7.7 . Disclosure was reported to the exchange on Sept. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Robert L. Hudkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 7.66 per share. | 15 Sep 2022 | 1,040 | 273,576 | - | 7.7 | 7,965 | Common Stock |
| Tyra Biosciences Inc | Robert L. Hudkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Robert L. Hudkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 8.53 per share. | 06 Sep 2022 | 2,408 | 272,536 | - | 8.5 | 20,529 | Common Stock |
| Tyra Biosciences Inc | Robert L. Hudkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 83,626 | 83,626 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Robert L. Hudkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 7,964 | 7,964 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Robert L. Hudkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 7,964 | 7,964 | - | - | Stock Option (Right to Buy) |